Naomi Kawashima, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Naomi Kawashima's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Naomi Kawashima has written about over time.
Hematologic NeoplasmsDonor SelectionTissue and Organ ProcurementChromosomes, Human, Pair 21Chromosomes, Human, Pair 8Gene Expression Regulation, LeukemicTranslocation, GeneticOncogene Proteins, FusionHematopoietic Stem Cell TransplantationDNA Repeat ExpansionCore Binding Factor Alpha 2 SubunitRepressor Proteinsfms-Like Tyrosine Kinase 3Leukemia, Myeloid, AcuteMutationThrombocythemia, Essential
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Hematologic Neoplasms | 3 | 2015 | 2018 | February 2017 |
| Donor Selection | 1 | 2018 | 2018 | January 2018 |
| Tissue and Organ Procurement | 1 | 2018 | 2018 | January 2018 |
| Chromosomes, Human, Pair 21 | 1 | 2018 | 2018 | September 2018 |
| Chromosomes, Human, Pair 8 | 1 | 2018 | 2018 | September 2018 |
| Gene Expression Regulation, Leukemic | 1 | 2018 | 2018 | September 2018 |
| Translocation, Genetic | 1 | 2018 | 2018 | September 2018 |
| Oncogene Proteins, Fusion | 2 | 2018 | 2018 | September 2018 |
| Hematopoietic Stem Cell Transplantation | 8 | 2017 | 2021 | October 2018 |
| DNA Repeat Expansion | 1 | 2020 | 2020 | May 2020 |
| Core Binding Factor Alpha 2 Subunit | 3 | 2018 | 2024 | December 2020 |
| Repressor Proteins | 2 | 2018 | 2024 | June 2021 |
| fms-Like Tyrosine Kinase 3 | 4 | 2019 | 2024 | June 2021 |
| Leukemia, Myeloid, Acute | 11 | 2017 | 2024 | August 2021 |
| Mutation | 8 | 2018 | 2024 | December 2021 |
| Thrombocythemia, Essential | 2 | 2024 | 2024 | June 2024 |